A detailed history of Ubs Group Ag transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,357 shares of ARMP stock, worth $4,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,357
Previous 1 235600.0%
Holding current value
$4,596
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.1 - $3.3 $4,947 - $7,774
2,356 Added 235600.0%
2,357 $5,000
Q2 2024

Aug 13, 2024

SELL
$2.4 - $3.9 $1,838 - $2,987
-766 Reduced 99.87%
1 $0
Q1 2024

May 13, 2024

BUY
$2.81 - $4.18 $2,152 - $3,201
766 Added 76600.0%
767 $3,000
Q4 2023

Feb 09, 2024

SELL
$1.95 - $3.24 $4,383 - $7,283
-2,248 Reduced 99.96%
1 $0
Q3 2023

Nov 09, 2023

BUY
$1.1 - $4.35 $2,472 - $9,778
2,248 Added 224800.0%
2,249 $6,000
Q2 2023

Aug 11, 2023

SELL
$1.14 - $1.7 $4,561 - $6,801
-4,001 Reduced 99.98%
1 $0
Q1 2023

May 12, 2023

SELL
$1.1 - $3.58 $3,207 - $10,439
-2,916 Reduced 42.15%
4,002 $6,000
Q4 2022

Feb 08, 2023

BUY
$0.94 - $4.16 $4,740 - $20,978
5,043 Added 268.96%
6,918 $8,000
Q3 2022

Nov 10, 2022

SELL
$3.12 - $4.92 $3,918 - $6,179
-1,256 Reduced 40.11%
1,875 $8,000
Q2 2022

Aug 10, 2022

BUY
$2.97 - $5.4 $1,158 - $2,106
390 Added 14.23%
3,131 $12,000
Q1 2022

May 16, 2022

BUY
$3.9 - $6.32 $2,749 - $4,455
705 Added 34.63%
2,741 $13,000
Q4 2021

Feb 14, 2022

SELL
$2.96 - $5.86 $2,563 - $5,074
-866 Reduced 29.84%
2,036 $11,000
Q3 2021

Nov 15, 2021

BUY
$3.55 - $4.14 $5,097 - $5,945
1,436 Added 97.95%
2,902 $11,000
Q2 2021

Aug 13, 2021

SELL
$3.89 - $4.87 $17,703 - $22,163
-4,551 Reduced 75.64%
1,466 $6,000
Q1 2021

May 12, 2021

BUY
$3.02 - $6.33 $7,688 - $16,116
2,546 Added 73.35%
6,017 $29,000
Q4 2020

Feb 11, 2021

BUY
$2.65 - $3.94 $9,195 - $13,671
3,470 Added 347000.0%
3,471 $10,000
Q3 2020

Nov 12, 2020

SELL
$2.96 - $4.04 $4,946 - $6,750
-1,671 Reduced 99.94%
1 $0
Q2 2020

Jul 31, 2020

SELL
$2.98 - $4.2 $1,805 - $2,545
-606 Reduced 26.6%
1,672 $7,000
Q1 2020

May 01, 2020

BUY
$2.58 - $4.85 $3,864 - $7,265
1,498 Added 192.05%
2,278 $7,000
Q4 2019

Feb 14, 2020

BUY
$3.16 - $4.54 $657 - $944
208 Added 36.36%
780 $3,000
Q3 2019

Nov 14, 2019

SELL
$3.35 - $4.72 $7,778 - $10,959
-2,322 Reduced 80.23%
572 $2,000
Q2 2019

Aug 14, 2019

BUY
$2.75 - $5.6 $7,958 - $16,206
2,894 New
2,894 $12,000

Others Institutions Holding ARMP

About Armata Pharmaceuticals, Inc.


  • Ticker ARMP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,144,700
  • Market Cap $70.5M
  • Description
  • Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...
More about ARMP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.